explore -WSS

explore

author：explore 2025-09-29 22:52:22 - browse：41

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： The cancer drug shortage isn’t new — and neither are the solutions

focus

WSS

Medical leaders decry Supreme Court decision on affirmative action

Republican states more likely to report Covid vaccine side effects

Young boy dies in trial for Pfizer Duchenne gene therapy

Trump demands the U.S. pay no more for drugs than other countries … again

Supreme Court strikes down use of affirmative action

Duchenne breakthrough therapy leaves behind pioneering families

leisure time

explore

explore

How one medical school became remarkably diverse

Medicare Advantage 2025 payments will dip, Biden administration says

Peter Hotez and the public health issue of online harassment

Cancer drug shortages should be causing more outrage

Jerome Adams on the need for new antivirals for Covid

Medicare Advantage 2025 payments will dip, Biden administration says

Dobbs anniversary: the lost opportunity of abortion as health care

Harvard scientists, with Google, unveil the most detailed brain map ever

Apple is now the first public company to be valued at $3 trillion

At least 13 dead in Texas as scorching temps continue

knowledge

The high cost of giving birth even with insurance

Mass General Brigham physicians react to latest merger step

U.K. decision on ALS drug has neurologists, advocates up in arms

Covid silver lining: Unprecedented look at human immune system

Pancreatic cancer is often deadly, but new discoveries are raising hope

Oral obesity drug from Viking Therapeutics hits key early target

entertainment

focus

explore

Wikipedia